Fujisawa, M
Sakata-Yanagimoto, M
Nishizawa, S
Komori, D
Gershon, P
Kiryu, M
Tanzima, S
Fukumoto, K
Enami, T
Muratani, M http://orcid.org/0000-0002-0276-8000
Yoshida, K
Ogawa, S
Matsue, K
Nakamura, N
Takeuchi, K http://orcid.org/0000-0002-1599-5800
Izutsu, K
Fujimoto, K
Teshima, T http://orcid.org/0000-0002-0941-271X
Miyoshi, H
Gaulard, P
Ohshima, K
Chiba, S
Article History
Received: 20 February 2017
Revised: 20 June 2017
Accepted: 17 July 2017
First Online: 23 August 2017
Competing interests
: SC received research funding from Bristol-Meyer Squibb that markets dasatinib.